广发纳斯达克生物科技C人民币(016470)
动态评分： 5.71分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2022-12-31 | CNTB | 康乃德生物 | 1.86 | 0.01% |
| 2022-12-31 | CRIS | 居里 | 2.4 | 0.01% |
| 2022-12-31 | CRVS | Corvus Pharmaceuticals Inc | 1.83 | 0.01% |
| 2022-12-31 | GRCL | 亘喜生物 | 2.35 | 0.01% |
| 2022-12-31 | GRNA | GreenLight Biosciences Inc | 2.66 | 0.01% |
| 2022-12-31 | HARP | Harpoon Therapeutics Inc | 1.1 | 0.01% |
| 2022-12-31 | IMRX | Immuneering Corp-A | 2.01 | 0.01% |
| 2022-12-31 | INFI | Infinity Pharmaceuticals Inc | 2 | 0.01% |
| 2022-12-31 | IVVD | Invivyd | 2.43 | 0.01% |
| 2022-12-31 | LPTX | Leap Therapeutics Inc | 1.74 | 0.01% |
| 2022-12-31 | MBIO | 野马生物 | 1.68 | 0.01% |
| 2022-12-31 | MGTA | Magenta Therapeutics Inc | 0.95 | 0.01% |
| 2022-12-31 | NLTX | Neoleukin Therapeutics Inc | 0.98 | 0.01% |
| 2022-12-31 | OCX | Oncocyte Corp | 1.62 | 0.01% |
| 2022-12-31 | OMER | 奥麦罗制药 | 2.18 | 0.01% |
| 2022-12-31 | QNCX | Quince Therapeutics Inc | 1 | 0.01% |
| 2022-12-31 | SABS | SAB Biotherapeutics Inc | 1.05 | 0.01% |
| 2022-12-31 | SURF | Surface Oncology Inc | 1.99 | 0.01% |
| 2022-12-31 | TCRR | TCR2 Therapeutics Inc | 1.58 | 0.01% |
| 2022-12-31 | AKAO | Achaogen Inc | 0.03 | 0% |
公告&资料
